Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LAB57 ApS
APS
Active
CVR 41328932
K. Christensens Vej 6, 9200
Aalborg SV
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2020 · 6 years old
— employees
www.lab57.dk
Monitor
Share
Denmark
/
Companies
/
Retail sale of pharmaceutical products
/
LAB57 ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-77
-23
-7
-22
-25
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-77
-23
-7
-22
-25
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-77
-23
-7
-22
-25
Net financials
-1
-1
23
-0
-0
Profit before tax
-79
-25
16
-22
-25
Tax
-17
-5
23
-0
-0
Net profit
-61
-19
-6
-22
-25
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
103
118
91
69
17
Equity
12
12
6
-16
-42
Long-term debt
0
0
0
0
0
Short-term debt
92
106
86
85
59
Total debt
92
106
86
85
59
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2535700.0%
This company
2021
2025
Equity ratio
-249.3%
This company
38.2%
Market median
-753% vs market
2021
2025
Return on equity
-2545300.0%
This company
18.4%
Market median
-13833252% vs market
2021
2025
Net profit margin (of gross profit)
-2545300.0%
This company
2021
2025
Asset turnover (of gross profit)
-1.51×
This company
2021
2025
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on LAB57 ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
